Conditions: Healthy
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 18
Healthy volunteers: yes

Brief summary:
The primary objective of the current study is to investigate the relative bioavailability of three trial formulations of BI 207127, the trial formulation 2 (TFII), the final formulation (FF), and a FF modified formulation. All formulations are supplied as film-coated Tablets and administered as single dose treatments of BI 207127 (3 film-coated Tablets) in healthy volunteers, with the aim to compare the bioavailability of the three formulations. All treatments will be applied fed, 30 minutes after start of the intake of a standard normal breakfast.

Detailed description:

Arms:
arm 1: Film-coated tablet for oral administration arm 2: Film-coated tablet for oral administration arm 3: Film-coated tablet for oral administration

Interventions: intervention 1: BI 207127 intervention 2: BI 207127 intervention 3: BI 207127
Intervention descriptions: intervention 1: Medium dose film-coated tablet intervention 2: Medium dose film-coated tablet intervention 3: Medium dose film-coated tablet

Protocol document: